Use of Signals and Systems Engineering to Improve the Safety of Warfarin Initiation

This publication has 13 references indexed in Scilit:

• Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy
  Thrombosis and Haemostasis, 2012
• Emergency Hospitalizations for Adverse Drug Events in Older Americans
  New England Journal of Medicine, 2011
• Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study design
  The Pharmacogenomics Journal, 2011
• Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients
  Journal of Thrombosis and Haemostasis, 2008
• Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin
  Clinical Pharmacology & Therapeutics, 2008
• The Effectiveness of Warfarin Dosing from a Nomogram Compared with House Staff Dosing
  The Journal of Arthroplasty, 2007
• Comparison of a Single End Point to Determine Optimal Initial Warfarin Dosing (5 mg Versus 10 mg) for Venous Thromboembolism
  The American Journal of Cardiology, 2006
• Tailoring warfarin induction doses to reflect individual and disease-specific factors
  The American Journal of Medicine, 2005
• Initiation of warfarin therapy in elderly medical inpatients: A safe and accurate regimen
  The American Journal of Medicine, 2005
• A Multicomponent Intervention To Prevent Major Bleeding Complications in Older Patients Receiving Warfarin
  Annals of Internal Medicine, 2000